American BioMed (ABMI) a strong buy recommendation of $5-6 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : American BioMed (ABMI) a strong buy recommendation of $5-6

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Lee who wrote ()	2/5/1997 12:59:00 PM
From: robert cartelli	of 463

American BioMed signs 3-year supply agreement with Joint Purchasing Corp. (JPC) to supply 380 hospitals BusinessWire, Wednesday, February 05, 1997 at 11:26 THE WOODLANDS, Texas--(BW HealthWire)--Feb. 5, 1997--American BioMed Inc. (NASDAQ OTC BB:ABMI) Wednesday announced that it has signed a 3-year distribution agreement with Joint Purchasing Corp. JPC is a hospital buying group which represents 380 hospitals located in the tri-state New York area. Product launch to all member hospitals is expected to begin within 30 days and to be completed over six months. The agreement includes American BioMed's 100% silicone balloon catheter line and its thermodilution catheters. Arthur S. Przybyl, VP Sales and Marketing, stated: "We are pleased that JPC has realized the importance of 100% silicone products and has recognized our product line's unique features and benefits. Specifically, there is no risk of adverse latex reaction when using American BioMed's silicone catheters in surgical procedures." The company anticipates an increase in its revenues for the first year of the agreement and substantial growth in subsequent years. American BioMed Inc. utilizes state of the art technology to develop, manufacture and market minimally invasive medical, surgical and diagnostic devices which deliver unique advantages through advanced science. Over 25 patents cover its technologies competing in an industry with combined markets estimated at over $10 billion annually. NOTE TO EDITORS: In the Internet/email address noted in this news release, there is an "at" symbol tewinc and aol.com. This symbol may not appear properly in some systems. CONTACT: Thomas E. Waite & Associates Inc. 407/324-1606, fax 407/324-0664 Email: tewinc@aol.com KEYWORD: FN TEXAS NEW YORK INDUSTRY KEYWORD: MEDICINE IS ANYBODY SUPRISED? KEEP BUYIN' R

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next